Savor all of the bureaucratese for yourself in the oh-so-brief 658-page rule, known to the cool kids as CMS-2345-FC. (Note: Not the name of a new Star Wars droid.)
The rule is effective April 1, 2016. (Seriously.) Below, I highlight what it could mean for drug channels, including observations on:
- Prescription reimbursement
- Pharmacy profits
- Manufacturers’ channel strategies
- Bona fide service fees
- Manufacturer-retail direct distribution arrangements
- And more!